Suss Microtec Se · XETR:SMHN

Suss Microtec — Q1 2026 Earnings Presentation

19 slides from Suss Microtec's earnings presentation, May 7, 2026

  1. Slide 1: Conference Call Q1 2026

    May 7, 2026 Conference Call Q1 2026 © SUSS

  2. Slide 2: Disclaimer

    Investor Presentation Disclaimer This presentation contains forward-looking statements relating to the business. financial performance and earnings of SUSS MicroTec SE and its subsidiaries and associates. Forward-looking statements are based on current plans, estimates, projections and expectations

  3. Slide 3: Agenda

    Investor Presentation Agenda 01 Key Messages Q1 2026 02 Key Financial Figures Q1 2026 03 Outlook 2026 © SUSS

  4. Slide 4: Key Messages Q1 2026

    Investor Presentation Agenda 01 Key Messages Q1 2026 02 Key Financial Figures Q1 2026 03 Outlook 2026 © SUSS

  5. Slide 5: Order intake at a record high

    Investor Presentation Order intake at a record high – Q1 expected to be the low point in sales over the course of the year Financial Results Q1 2026 149.3 86.5 36.1 4.3 in € million in € million in % in % Order intake Sales Gross profit margin EBIT margin Q1 2026 Q1 2026 Q1 2026 Q1 2026 +69.5% YoY -

  6. Slide 6: Key CEO messages

    Investor Presentation Key CEO messages We entered the new fiscal year with very strong customer demand, recording €149.3 million in order intake from January to March – the highest quarterly figure in the company’s history. Both, Advanced Backend Solutions and Photomask Solutions contributed. On the

  7. Slide 7: Segment Overview Q1 2026

    Investor Presentation Segment Overview Q1 2026 Advanced Backend Solutions Photomask Solutions in € million Q1 2026 Q1 2025 in € million Q1 2026 Q1 2025 Order intake 99.7 54.3 Order intake 49.6 33.7 Order book as of March 31 229.8 241.5 Order book as of March 31 100.4 149.5 Sales 55.7 83.8 Sales 30.8

  8. Slide 8: Key Financial Figures Q1 2026

    Investor Presentation Agenda 01 Key Messages Q1 2026 02 Key Financial Figures Q1 2026 03 Outlook 2026 © SUSS

  9. Slide 9: Strong sales growth and higher CapEx

    Investor Presentation Strong sales growth and higher CapEx in € million Q1 2026 Q1 2025 Change • Order book of €330.1 million, of which the Order intake 149.3 88.1 +69.5% majority is scheduled for delivery and revenue recognition in 2026 Order book as of March 31 330.1 391.0 -15.6% • Sales reflect t

  10. Slide 10: Order intake momentum remains positive

    Investor Presentation Order intake momentum remains positive; EBIT margin under pressure due to lower cost absorption Order intake Sales €149.3m (Q1 2026) €86.5m (Q1 2026) 141.7 124.9 119.0 117.6 117.5 88.1 78.8 70.0 86.5 149.3 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Sales of €86.5 million reflect Gross profit marg

  11. Slide 11: Significantly stronger order intake in both segments

    Investor Presentation Significantly stronger order intake in both segments in the first quarter Order intake Sales Gross profit margin EBIT margin (Q1 2026) (Q1 2026) (Q1 2026) (Q1 2026) €149.3m €86.5m 36.1% 4.3% Order intake by quarters Sales by quarters Gross profit margin by quarters EBIT margin

  12. Slide 12: Order Intake by Segment and Region

    Investor Presentation Order Intake by Segment (in €m) and Region (in %) Book-to-bill ratio Order Intake Q1 2026: 1.73 by Region Q1 2026 149,3 147,5 117,5 EMEA 98,3 93,9 88,0 84,0 78,7 15.6% 70,0 Americas 19.4% Asia/ 65.0% Pacific Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 €423.7m €354.3m €149.3m FY 2024 FY

  13. Slide 13: Less working capital and an increase in cash and cash equivalents

    Investor Presentation Less working capital and an increase in cash and cash equivalents. Assets in € million 1 Decline of non-current assets through 507.4 524.7 depreciation that exceeded CapEx. Non-current 2 Inventory increased by €14.0 million in Q1 1 118.8 2026 to €185.6 million due to higher wor

  14. Slide 14: Increase in current liabilities as part of working capital

    Investor Presentation Increase in current liabilities as part of working capital Liabilities and equity in € million 524.7 507.4 Equity ratio: 1 Equity increased by €3.2.million due to net Equity ratio: 60.7% income of €2.5 million and OCI by €0.7 62.2% million. Equity ratio at 60.7 %. 2 No major ch

  15. Slide 15: Outlook 2026

    Investor Presentation Agenda 01 Key Messages Q1 2026 02 Key Financial Figures Q1 2026 03 Outlook 2026 © SUSS

  16. Slide 16: Strong order intake has improved visibility

    Investor Presentation Strong order intake has improved visibility and will support operational stabilization throughout the year Sales achieved in Q1 2026 € 86.5 million Order book as of March 31, 2026, of which the majority is expected to be executed in 2026 € 330.1 million © SUSS 16

  17. Slide 17: Transition year 2026

    Investor Presentation Transition year 2026: A temporary dip in sales is expected, leading to lower fixed-cost coverage and, together with rising R&D expenses, to a lower EBIT margin while the gross profit margin remains broadly stable Guidance 2026 (as of March 30, 2026) Sales Gross profit EBIT marg

  18. Slide 18: Thank you

    Thank you Growing Innovation Florian Mangold Manager Investor Relations Tel.: +49 89 32007-306 E-mail: florian.mangold@suss.com

  19. Slide 19: Investor Relations information

    Investor Presentation Investor Relations information Conference and Roadshow Calendar Financial Calendar May 19, 2026 May 7, 2026 Roadshow (Kepler) | Paris Interim Statement as of March 31, 2026 May 20, 2026 June 3, 2026 UBS Technology, Media and Internet Conference | London Annual General Meeting,

SUSS MicroTec — Q1 2026 Earnings Presentation on 6ix